20
Anjan Drug Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DIVALPROEX SODIUM USP, with a corresponding US DMF Number 20036.
Remarkably, this DMF maintains an Active status since its submission on December 14, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on November 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II